Role of rs490683 variant in the promoter region of the ghrelin receptor gene on body weight and metabolic syndrome after a partial meal replacement hypocaloric diet
Daniel de Luis, Olatz Izaola, David Primo, Daniel Rico, Juan Jose López
{"title":"Role of rs490683 variant in the promoter region of the ghrelin receptor gene on body weight and metabolic syndrome after a partial meal replacement hypocaloric diet","authors":"Daniel de Luis, Olatz Izaola, David Primo, Daniel Rico, Juan Jose López","doi":"10.1016/j.jdiacomp.2025.109062","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aims</h3><div>Few studies have evaluated the effect of rs490683 on weight loss. The objective of our study was to evaluate the role of this variant of <em>GHSR</em> gene on body weight loss and cardiovascular risk factors secondary to a partial meal replacement (pMR) hypocaloric diet.</div></div><div><h3>Methods</h3><div>96 individuals with a body mass index (BMI > 35 kg/m<sup>2</sup>) were enrolled. Participants consumed a normocaloric, hyperproteic formula twice daily (12-w). Measurements were taken for body weight, BMI, fat mass, waist circumference, blood pressure, lipid profile, fasting insulin levels and HOMA-IR.</div></div><div><h3>Results</h3><div>The genotype was 70 patients (72.9 %) CC genotype, 19 patients(19.8 %) CG genotype, and 7 patients(7.3 %) GG genotype. The intake of calories, grams of carbohydrates, fats and proteins was higher at 12w in patients carrying the G allele. BMI (−3.5 ± 0.4 kg/m<sup>2</sup> vs −1.0 ± 0.2 kg/m<sup>2</sup> (<em>p</em> = 0.01)), body weight (−8.5 ± 1.0 kg vs −2.6 ± 1.1 kg (<em>p</em> = 0.01)), fat mass (−7.7 ± 0.3 kg vs −2.6 ± 0.2 kg (<em>p</em> = 0.01)), waist circumference (−7.2 ± 0.3 cm vs −2.9 ± 0.1 cm (<em>p</em> = 0.01)), glucose levels (−12.1 ± 1.4 mg/dl vs −3.1 ± 1.8 mg/dl, <em>p</em> = 0.01), insulin (−10.8 ± 1.2 UI/L vs −3.9 ± 1.1 UI/L, <em>p</em> = 0.01), HOMA-IR (−2.1 ± 1.0 units vs −0.58 ± 0.2 units, <em>p</em> = 0.01), CRP (−1.2 ± 0.1 mg/dl vs −0.7 ± 0.2 mg/dl, <em>p</em> = 0.01), triglycerides (−22.1 ± 4.1 mg/dl vs −5.1 ± 3.2 mg/dl, <em>p</em> = 0.01), total-cholesterol (−22.2 ± 1.3 mg/dl vs −8.8 ± 1.9 mg/dl, <em>p</em> = 0.01), LDL-cholesterol (−15.2 ± 1.1 mg/dl vs −4.7 ± 1.2 mg/dl, p = 0.01), and HDL-cholesterol (6.2 ± 0.4 mg/dl vs −2.9 ± 1.2 mg/dl, p = 0.01) modifications were better in non-G allele carriers. After intervention, the odds ratio (OR) of MS in non-carrier of G allele improved OR 0.48 (95%CI: 0.31–0.73; <em>p</em> = 0.02).</div></div><div><h3>Conclusions</h3><div>G allele of rs490683 have a deleterious effect on dietary restrictions, body weight and metabolic response after a pMR diet.</div></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":"39 8","pages":"Article 109062"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes and its complications","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056872725001151","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims
Few studies have evaluated the effect of rs490683 on weight loss. The objective of our study was to evaluate the role of this variant of GHSR gene on body weight loss and cardiovascular risk factors secondary to a partial meal replacement (pMR) hypocaloric diet.
Methods
96 individuals with a body mass index (BMI > 35 kg/m2) were enrolled. Participants consumed a normocaloric, hyperproteic formula twice daily (12-w). Measurements were taken for body weight, BMI, fat mass, waist circumference, blood pressure, lipid profile, fasting insulin levels and HOMA-IR.
Results
The genotype was 70 patients (72.9 %) CC genotype, 19 patients(19.8 %) CG genotype, and 7 patients(7.3 %) GG genotype. The intake of calories, grams of carbohydrates, fats and proteins was higher at 12w in patients carrying the G allele. BMI (−3.5 ± 0.4 kg/m2 vs −1.0 ± 0.2 kg/m2 (p = 0.01)), body weight (−8.5 ± 1.0 kg vs −2.6 ± 1.1 kg (p = 0.01)), fat mass (−7.7 ± 0.3 kg vs −2.6 ± 0.2 kg (p = 0.01)), waist circumference (−7.2 ± 0.3 cm vs −2.9 ± 0.1 cm (p = 0.01)), glucose levels (−12.1 ± 1.4 mg/dl vs −3.1 ± 1.8 mg/dl, p = 0.01), insulin (−10.8 ± 1.2 UI/L vs −3.9 ± 1.1 UI/L, p = 0.01), HOMA-IR (−2.1 ± 1.0 units vs −0.58 ± 0.2 units, p = 0.01), CRP (−1.2 ± 0.1 mg/dl vs −0.7 ± 0.2 mg/dl, p = 0.01), triglycerides (−22.1 ± 4.1 mg/dl vs −5.1 ± 3.2 mg/dl, p = 0.01), total-cholesterol (−22.2 ± 1.3 mg/dl vs −8.8 ± 1.9 mg/dl, p = 0.01), LDL-cholesterol (−15.2 ± 1.1 mg/dl vs −4.7 ± 1.2 mg/dl, p = 0.01), and HDL-cholesterol (6.2 ± 0.4 mg/dl vs −2.9 ± 1.2 mg/dl, p = 0.01) modifications were better in non-G allele carriers. After intervention, the odds ratio (OR) of MS in non-carrier of G allele improved OR 0.48 (95%CI: 0.31–0.73; p = 0.02).
Conclusions
G allele of rs490683 have a deleterious effect on dietary restrictions, body weight and metabolic response after a pMR diet.
期刊介绍:
Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers, that publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular aspects of glucose homeostasis.
The primary purpose of JDC is to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications.
Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.